Table 1. Basic and clinical parameters of F0, F1, F2, F3, and F4 groups of patients selected for the study (N = 115).

Patients Group	Age (Mean ± SD)	Sex (M/F)	AST (IU/liter) (Mean ± SD)	ALT (IU/liter) (Mean ± SD)	γ-GT (IU/liter) (Mean ± SD)	Albumin (g/100 mL) (Mean ± SD)
F0	65 ± 6.3	5/6 (N = 11)	23.2 ± 5.0	25.6 ± 7.5	28.5 ± 8.3	4.5 ± 0.3
F1	62 ± 7.7	12/16 (N = 36)	35.3 ± 10.8	36.4 ± 14.5	25.7 ± 11.7	4.2 ± 0.3
F2	58 ± 5.9	17/9 (N = 26)	56.6 ± 17.1*	76.5 ± 34.9***	61.5 ± 34.5**	4.2 ± 0.3
F3	63 ± 3.6	11/11 (N = 22)	43.9 ± 14.1*	48.4 ± 22.9*	29.8 ± 9.3	3.9 ± 0.2*
F4	69 ± 4.8	10/10 (N = 20)	54.2 ± 5.8**	48.2 ± 15.5*	38.0 ± 9.7	3.4 ± 0.4***

*P < 0.05

**P < 0.01, and

***P < 0.001 compared to F0